Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ludwig Cancer Research is an international non-profit organization dedicated to understanding and controlling cancer through high-impact basic and clinical research. Established in 1971 by Daniel K. Ludwig, the organization operates through the Ludwig Institute for Cancer Research and a network of Ludwig Centers at premier academic institutions. It is a world leader in cancer immunology, credited with the discovery of numerous tumor antigens and the development of innovative immunotherapies and vaccines. Ludwig bridges the gap between laboratory discovery and clinical application by conducting its own clinical trials and partnering with biotechnology and pharmaceutical companies for commercialization. Its collaborative model integrates scientists and clinicians globally to accelerate the translation of scientific breakthroughs into life-saving treatments.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ludwig Cancer Research Center.